D
Dyne Therapeutics, Inc. DYN
$10.05 $0.202.03% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -60.28% -42.63% -34.54% -41.51% -36.08%
Total Depreciation and Amortization 17.21% 8.62% 0.00% -3.16% -1.58%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 13.43% 3.81% 116.51% 113.11% 111.04%
Change in Net Operating Assets 670.98% 595.36% -174.09% 87.45% 138.81%
Cash from Operations -64.17% -45.47% -55.38% -33.29% -25.48%
Capital Expenditure -82.65% -358.84% -225.93% -18.61% 31.19%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 80.67% 84.04% -340.00% -307.03% -209.63%
Cash from Investing 79.03% 81.57% -344.96% -312.00% -212.55%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -79.10% 25.09% 1,390.92% 782.49% 766.93%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -66.58% 25.09% 1,390.92% 782.49% 766.93%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -127.96% 121.21% 720.39% 2,847.34% 1,291.43%